Literature DB >> 9790337

Carotid endarterectomy by eversion technique: its safety and durability.

D M Shah1, R C Darling, B B Chang, P S Paty, P B Kreienberg, W E Lloyd, R P Leather.   

Abstract

SUMMARY BACKGROUND DATA: The outcome of standard longitudinal carotid endarterectomy (CEA) can be measured by preservation of neurologic function with a low incidence of restenosis. Closure of the internal carotid arteriotomy with or without a patch may predispose to restenosis. Alternatively, transection of the internal carotid artery at the bulb with eversion endarterectomy allows expeditious removal of the plaque and direct visualization of the endpoint. Because the proximal internal carotid artery is anastomosed to the common carotid artery, this obviates the need for patch closure. The authors report their results with this technique in more than 2200 procedures.
METHODS: From May 1993 to March 1998, 1855 patients underwent 2249 CEAs using the eversion technique. During the same period, 410 patients had 474 CEAs by standard technique. Three hundred fifteen procedures in the eversion group and 65 procedures in the standard group were combined CEA and coronary artery bypass grafts. Most solo CEAs (97%) were performed in awake patients using regional anesthesia. Shunts were used on demand in 6% of CEAs.
RESULTS: The operative mortality rate was 1.02% (16/1575) in the solo eversion group and 2.2% (9/410) in the standard group. There were 18 permanent neurologic deficits (0.8%) in the eversion group and 11 (2.3%) in the standard group. Transient neurologic deficits occurred in 20 patients (0.9%) in the eversion group and 13 patients (2.7%) in the standard group. Of the 1855 patients, 1786 (96%) presented for duplex ultrasound follow-up. There were seven (0.3%) stenoses greater than 60% in the eversion group versus five (1.1%) in the standard group.
CONCLUSIONS: Eversion CEA can be performed safely with a low rate of stroke and death and a minimal restenosis rate in short- and long-term follow-up.

Entities:  

Mesh:

Year:  1998        PMID: 9790337      PMCID: PMC1191519          DOI: 10.1097/00000658-199810000-00004

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  28 in total

1.  Surgical considerations of occlusive disease of innominate, carotid, subclavian, and vertebral arteries.

Authors:  M E DE BAKEY; E S CRAWFORD; D A COOLEY; G C MORRIS
Journal:  Ann Surg       Date:  1959-05       Impact factor: 12.969

2.  Closure of the internal carotid artery after endarterectomy: the advantages of patch angioplasty without its disadvantages.

Authors:  R Vanmaele; P Van Schil; M De Maeseneer
Journal:  Ann Vasc Surg       Date:  1990-01       Impact factor: 1.466

3.  Use of the internal jugular vein for carotid patch angioplasty.

Authors:  G R Seabrook; J B Towne; D F Bandyk; D D Schmitt; E B Cohen
Journal:  Surgery       Date:  1989-10       Impact factor: 3.982

4.  A simple technic for carotid endarterectomy.

Authors:  S N Etheredge
Journal:  Am J Surg       Date:  1970-08       Impact factor: 2.565

5.  Comparison of perioperative results obtained with carotid eversion endarterectomy and with conventional patch plasty.

Authors:  L Entz; Z Járányi; A Nemes
Journal:  Cardiovasc Surg       Date:  1997-02

6.  Prospective randomized trial of carotid endarterectomy with primary closure and patch angioplasty with saphenous vein, jugular vein, and polytetrafluoroethylene: long-term follow-up.

Authors:  A F AbuRahma; P A Robinson; S Saiedy; J H Kahn; J P Boland
Journal:  J Vasc Surg       Date:  1998-02       Impact factor: 4.268

7.  An outcome analysis of carotid endarterectomy: the incidence and natural history of recurrent stenosis.

Authors:  R E Carballo; J B Towne; G R Seabrook; J A Freischlag; R A Cambria
Journal:  J Vasc Surg       Date:  1996-05       Impact factor: 4.268

8.  Saphenous vein patch versus primary closure for carotid endarterectomy: long-term assessment of a randomized prospective study.

Authors:  S I Myers; R J Valentine; A Chervu; B L Bowers; G P Clagett
Journal:  J Vasc Surg       Date:  1994-01       Impact factor: 4.268

9.  Vein patch versus primary closure for carotid endarterectomy. A randomized prospective study in a selected group of patients.

Authors:  G P Clagett; C B Patterson; D F Fisher; R E Fry; J F Eidt; T H Humble; W J Fry
Journal:  J Vasc Surg       Date:  1989-02       Impact factor: 4.268

10.  Eversion endarterectomy of the internal carotid artery: midterm results of a new technique.

Authors:  B Reigner; P Reveilleau; M Gayral; X Papon; B Enon; J M Chevalier
Journal:  Ann Vasc Surg       Date:  1995-05       Impact factor: 1.466

View more
  5 in total

1.  Completion angioscopy following carotid endarterectomy by the eversion technique or the standard longitudinal arteriotomy with patch closure.

Authors:  H Y Osman; C P Gibbons
Journal:  Ann R Coll Surg Engl       Date:  2001-05       Impact factor: 1.891

2.  A comparison of results with eversion versus conventional carotid endarterectomy from the Vascular Quality Initiative and the Mid-America Vascular Study Group.

Authors:  Joseph R Schneider; Irene B Helenowski; Cheryl R Jackson; Michael J Verta; Kimberly C Zamor; Nilesh H Patel; Stanley Kim; Andrew W Hoel
Journal:  J Vasc Surg       Date:  2015-05       Impact factor: 4.268

3.  Routine Shunting is Safe and Reliable for Cerebral Perfusion during Carotid Endarterectomy in Symptomatic Carotid Stenosis.

Authors:  Tae Yun Kim; Jong Bum Choi; Kyung Hwa Kim; Min Ho Kim; Byoung-Soo Shin; Hyun Kyu Park
Journal:  Korean J Thorac Cardiovasc Surg       Date:  2012-04-03

4.  A prospective randomized study on bilateral carotid endarterectomy: patching versus eversion.

Authors:  E Ballotta; L Renon; G Da Giau; A Toniato; C Baracchini; E Abbruzzese; M Saladini; P Moscardo
Journal:  Ann Surg       Date:  2000-07       Impact factor: 12.969

5.  Comparative results of conventional and eversion carotid endarterectomy.

Authors:  Jae Hoon Lee; Bo Yang Suh
Journal:  Ann Surg Treat Res       Date:  2014-09-25       Impact factor: 1.859

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.